GO:0140744 negative regulation of lncRNA transcription: Repression Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140744 (negative regulation of lncRNA transcription) describes any process that decreases the frequency, rate or extent of long non-coding RNA synthesis.
• lncRNA repression is frequently achieved by epigenetic silencing complexes that remove activating marks or deposit repressive marks on chromatin.
• Dysregulated lncRNA repression contributes to cancer progression, including triple-negative breast cancer and osteoclast-driven bone disease.
• Key effectors include HDAC1/2-containing deacetylase complexes, MTA1, and hormone-responsive transcription factors such as the vitamin D receptor.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test whether a candidate regulator causally controls lncRNA transcription.
• Combining RNA-seq, ChIP, and CRISPR screening provides a systematic route to map the negative regulatory network of lncRNAs.
Description
Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides that do not encode proteins but regulate chromatin, transcription and splicing. The Gene Ontology term GO:0140744, negative regulation of lncRNA transcription, captures any process that decreases the frequency, rate or extent of lncRNA synthesis. Because lncRNA abundance is tightly controlled, repression is as important as activation for normal development and disease. Studies in osteoclastogenesis show that lncRNA expression profiles are dynamically shaped by negative regulatory inputs, and that lncRNA-NOMMUT037835.2 is itself subject to negative regulation during osteoclast differentiation. In triple-negative breast cancer, miRNA and lncRNA networks cooperate to silence or amplify oncogenic programs, illustrating how lncRNA repression influences tumor biology. The term is therefore central to understanding how cells switch lncRNA programs on and off. Researchers studying GO:0140744 need to identify the transcription factors, epigenetic modifiers and non-coding effectors that repress lncRNA loci, and to test causality with genome-editing models. This article summarizes the definition, mechanism, key genes, disease links and experimental methods for negative regulation of lncRNA transcription.
negative regulation of lncRNA transcription At A Glance
| GO ID | GO:0140744 |
|---|---|
| GO term | negative regulation of lncRNA transcription |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the frequency, rate or extent of lncRNA synthesis |
| Biological context | Epigenetic silencing, transcription factor repression, chromatin remodeling at lncRNA loci |
| Representative regulators | HDAC1/2-containing complexes, MTA1, hormone receptors, lncRNA-directed effectors |
| Disease relevance | Cancer, osteoclastogenesis, inflammatory and metabolic disorders |
| Research methods | RNA-seq, ChIP-seq, CRISPR KO/knock-in, overexpression, library screening |
What Is GO:0140744?
GO:0140744 (negative regulation of lncRNA transcription) is a biological process defined as any process that decreases the frequency, rate or extent of the synthesis of a lncRNA. In practice, this includes recruitment of transcriptional repressors to lncRNA promoters, deposition of repressive chromatin marks, removal of activating histone acetylation, and interference with RNA polymerase II elongation at lncRNA loci. The term is the negative counterpart of lncRNA transcription and is distinct from lncRNA degradation, because it acts on synthesis rather than stability.
Why Is negative regulation of lncRNA transcription Important in Cell Biology?
Negative regulation of lncRNA transcription is important because lncRNAs act as scaffolds, decoys and guides that shape gene expression programs, and their inappropriate activation or silencing can drive disease. For example, HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1/2 deacetylase complex to cccDNA minichromosomes, showing that lncRNA repression is mechanistically linked to deacetylation and chromatin compaction. In basal subtype breast cancer, lncRNA-mediated regulation of SOX9 expression influences cell identity, and perturbation of such lncRNA control can alter tumor phenotypes. In triple-negative breast cancer, miRNA and lncRNA networks are dysregulated, and understanding which lncRNAs are repressed versus activated is critical for biomarker and therapeutic development. In osteoclastogenesis, negative regulation of lncRNA-NOMMUT037835.2 modulates differentiation, linking lncRNA repression to bone remodeling. Finally, vitamin D reduces Th17 differentiation in ulcerative colitis by targeting the lncRNA OIP5-AS1/miR-26a-5p/IL-6 axis, demonstrating that lncRNA repression can be pharmacologically manipulated.
• Controls lncRNA dosage, preventing inappropriate activation of oncogenic or inflammatory lncRNA programs.
• Links epigenetic modifiers such as HDAC1/2 and MTA1 to repression of viral and cellular lncRNA transcription.
• Shapes osteoclast differentiation through negative regulation of lncRNA-NOMMUT037835.2.
• Contributes to triple-negative breast cancer biology via miRNA-lncRNA regulatory networks.
• Modulates SOX9 expression and basal breast cancer cell identity through lncRNA control.
• Can be targeted by vitamins and hormones, as shown for vitamin D and the OIP5-AS1/miR-26a-5p/IL-6 axis in ulcerative colitis.
• Provides a mechanistic entry point for CRISPR screens that map repressors of lncRNA loci.
• Helps explain how fungal and plant lncRNAs are controlled by transactivators and splicing under stress.
What Happens During negative regulation of lncRNA transcription?
Recruitment of repressive complexes to lncRNA loci
In simple terms: Repressor proteins are brought to the DNA region that controls the lncRNA, turning it down.
Negative regulation of lncRNA transcription begins when sequence-specific transcription factors or lncRNA-directed guides recruit repressive complexes to lncRNA promoters and enhancers. HOXA-AS2 recruits the MTA1-HDAC1/2 deacetylase complex to cccDNA minichromosomes, providing a direct example of how a lncRNA-associated complex can be targeted to a transcription unit to repress it. In basal breast cancer cells, lncRNA-mediated regulation of SOX9 expression shows that lncRNA loci are embedded in transcription factor circuits that can be repressed or activated depending on cellular context.
Chromatin modification and deacetylation
In simple terms: Chemical tags on histone proteins are removed or added to make the lncRNA gene less active.
Once recruited, repressive complexes modify chromatin to reduce lncRNA synthesis. The MTA1-HDAC1/2 complex removes acetyl groups from histones at target loci, promoting a compact chromatin state that inhibits transcription. Epigenetic regulation of triple-negative breast cancer by TGF-beta signaling further illustrates how signaling-driven chromatin changes can silence or activate lncRNA programs. These modifications decrease the frequency and rate of lncRNA synthesis, matching the GO:0140744 definition.
Transcriptional interference and elongation control
In simple terms: The cell can also slow down or block the copying of the lncRNA after it has started.
Negative regulation can occur after initiation by limiting RNA polymerase II elongation or by transcriptional interference from neighboring transcription units. In Medicago truncatula, negative regulation of seed germination by the lncRNA MtCIR1 under salt stress is associated with alternative splicing, indicating that lncRNA control intersects with co-transcriptional RNA processing. In fungi, a lncRNA can act on a transactivator to regulate gene expression, showing that lncRNA repression can be indirect and mediated by protein partners.
Hormonal and signaling control of lncRNA repression
In simple terms: Signals from outside the cell, such as vitamin D, can switch lncRNA repression on.
Extracellular signals tune negative regulation of lncRNA transcription. Vitamin D reduces Th17 differentiation in ulcerative colitis patients by targeting the lncRNA OIP5-AS1/miR-26a-5p/IL-6 axis, demonstrating that a hormonal signal can repress a lncRNA-centered network. In osteoclastogenesis, lncRNA expression profiles change during differentiation, and lncRNA-NOMMUT037835.2 is subject to negative regulation, linking cytokine signaling to lncRNA repression. These examples show that GO:0140744 is responsive to physiological and pathological cues.
Feedback and network-level repression
In simple terms: Repressing one lncRNA can change many other RNAs, forming a network.
Because lncRNAs often regulate other lncRNAs and miRNAs, negative regulation at one locus can propagate through a network. In triple-negative breast cancer, miRNA and lncRNA roles are intertwined, so repression of a single lncRNA can alter multiple downstream targets. Epigenetic regulation by TGF-beta signaling in TNBC further supports network-level control of lncRNA transcription. Such feedback explains why GO:0140744 is best studied with genome-wide methods rather than single-locus assays.
Key Genes Involved in GO:0140744 negative regulation of lncRNA transcription
The following genes and proteins have been experimentally implicated in negative regulation of lncRNA transcription or in lncRNA-mediated repression of target transcription units.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTA1 | Component of the MTA1-HDAC1/2 deacetylase complex that represses transcription | Recruited by HOXA-AS2 to cccDNA to inhibit HBV transcription |
| HDAC1 | Histone deacetylase that removes acetyl marks and compacts chromatin | Part of the MTA1-HDAC1/2 complex mediating lncRNA-directed repression |
| HDAC2 | Histone deacetylase partnering with HDAC1 in repressive complexes | Required for HOXA-AS2-mediated epigenetic inhibition of HBV transcription |
| HOXA-AS2 | lncRNA that guides the MTA1-HDAC1/2 complex to target loci | Epigenetically inhibits HBV transcription via cccDNA minichromosome recruitment |
| SOX9 | Transcription factor whose expression is regulated by lncRNAs | LncRNA-mediated regulation of SOX9 in basal subtype breast cancer cells |
| OIP5-AS1 | lncRNA targeted by vitamin D in Th17 differentiation | Vitamin D reduces Th17 differentiation via OIP5-AS1/miR-26a-5p/IL-6 axis |
| MIR26A5P | MicroRNA that interacts with OIP5-AS1 and IL-6 signaling | Part of the vitamin D-responsive lncRNA-miRNA axis in ulcerative colitis |
| IL6 | Cytokine downstream of the OIP5-AS1/miR-26a-5p axis | Modulated by vitamin D in ulcerative colitis Th17 cells |
| NOMMUT037835.2 | lncRNA negatively regulated during osteoclastogenesis | Expression profiling and negative regulation in osteoclast differentiation |
| MtCIR1 | lncRNA negatively regulating seed germination under salt stress | Associated with alternative splicing in Medicago truncatula |
| TGFB1 | Signaling ligand that drives epigenetic regulation in TNBC | Epigenetic regulation of triple negative breast cancer by TGF-beta signaling |
| VDR | Vitamin D receptor mediating hormonal repression of lncRNA networks | Vitamin D targeting of OIP5-AS1 axis in ulcerative colitis |
| MIRNA | MicroRNAs that cooperate with lncRNAs in regulatory networks | Roles of miRNA and lncRNA in triple-negative breast cancer |
| Fungal lncRNA | lncRNA acting on a transactivator to regulate gene expression | Regulation of gene expression by a fungal lncRNA |
| Transactivator | Protein partner through which fungal lncRNA exerts control | Mechanistic study of lncRNA action on a transactivator |
| Splicing factors | Machinery linking lncRNA repression to alternative splicing | MtCIR1-associated alternative splicing under salt stress |
| Th17 program genes | Differentiation program modulated by lncRNA repression | Vitamin D and OIP5-AS1 axis in ulcerative colitis |
| Osteoclast genes | Differentiation program shaped by lncRNA negative regulation | lncRNA-NOMMUT037835.2 in osteoclastogenesis |
How Is negative regulation of lncRNA transcription Regulated?
Negative regulation of lncRNA transcription is itself regulated by signaling pathways and epigenetic enzymes. TGF-beta signaling drives epigenetic changes in triple-negative breast cancer that can repress or activate lncRNA loci. Vitamin D signaling, acting through the vitamin D receptor, represses the OIP5-AS1/miR-26a-5p/IL-6 axis during Th17 differentiation in ulcerative colitis. In osteoclastogenesis, differentiation cues dynamically change lncRNA expression profiles, and lncRNA-NOMMUT037835.2 is negatively regulated during this process. In plants, salt stress triggers negative regulation of seed germination by MtCIR1 in association with alternative splicing. In fungi, a lncRNA can regulate gene expression by acting on a transactivator, showing that lncRNA repression can be embedded in protein-level feedback loops. Together, these findings indicate that GO:0140744 is controlled by hormone signaling, cytokine signaling, stress responses and chromatin-modifying complexes.
negative regulation of lncRNA transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HOXA-AS2 / MTA1 / HDAC1/2 | HBV infection and liver disease | HBV cccDNA reporter cells with HOXA-AS2 knockout or HDAC1/2 point mutation |
| SOX9 / lncRNA axis | Basal subtype breast cancer | Breast cancer cell lines with lncRNA knockout and SOX9 knock-in reporters |
| OIP5-AS1 / MIR26A5P / IL6 | Ulcerative colitis and Th17 differentiation | Primary T cells or Jurkat models with OIP5-AS1 overexpression and knockout |
| NOMMUT037835.2 | Osteoclastogenesis and bone remodeling | RAW264.7 or primary osteoclast cultures with lncRNA knockout |
| MtCIR1 | Salt stress and seed germination | Medicago truncatula lines with MtCIR1 knockout or overexpression |
Triple-negative breast cancer
Triple-negative breast cancer (TNBC) is characterized by dysregulated miRNA and lncRNA networks, and epigenetic regulation by TGF-beta signaling reshapes lncRNA transcription in these tumors. LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells further links lncRNA control to tumor cell identity. Negative regulation of lncRNA transcription can therefore either suppress or promote oncogenic programs depending on the lncRNA and context.
HBV infection and liver disease
HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1/2 deacetylase complex to cccDNA minichromosomes. This demonstrates that lncRNA-directed repression of transcription is directly relevant to viral persistence and liver disease, and that deacetylase complexes are actionable targets.
Inflammatory bowel disease and osteoclast-driven bone disease
Vitamin D reduces Th17 differentiation in ulcerative colitis patients by targeting the lncRNA OIP5-AS1/miR-26a-5p/IL-6 axis, connecting lncRNA repression to inflammatory disease. In bone, lncRNA-NOMMUT037835.2 is negatively regulated during osteoclastogenesis, linking GO:0140744 to osteoclast differentiation and bone remodeling.
Plant and fungal models of lncRNA repression
In Medicago truncatula, the lncRNA MtCIR1 negatively regulates seed germination under salt stress in association with alternative splicing. In fungi, a lncRNA regulates gene expression by acting on a transactivator. These non-human systems provide genetically tractable models for dissecting conserved principles of lncRNA repression.
From negative regulation of lncRNA transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate repressor required for lncRNA silencing? | CRISPR knockout of the repressor gene followed by RNA-seq |
| Does a specific residue in a repressor mediate lncRNA repression? | Point-mutation knock-in of the catalytic or interaction residue |
| Does a repressive complex bind a specific lncRNA promoter? | Tagged knock-in of the repressor with ChIP-seq |
| Does overexpression of a lncRNA repress a target locus? | Doxycycline-inducible overexpression cell line |
| Which genes globally repress lncRNA transcription? | Genome-wide CRISPR knockout library screening with lncRNA reporters |
| Does a hormonal signal repress a lncRNA network? | Ligand-treated cells with receptor knockout and RNA-seq |
How to Study the negative regulation of lncRNA transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state lncRNA and mRNA abundance | Profiling lncRNA changes after repressor perturbation |
| ChIP-seq | Genome-wide binding of repressive complexes | Mapping MTA1-HDAC1/2 recruitment to target loci |
| Histone modification assays | Acetylation and methylation status at lncRNA promoters | Confirming repressive chromatin changes |
| CRISPR knockout screening | Genes required for lncRNA repression | Genome-wide discovery of negative regulators |
| Reporter assays | Transcriptional activity of a lncRNA promoter | Testing direct repression by candidate factors |
| Alternative splicing assays | Splicing isoforms associated with lncRNA repression | Plant salt stress studies with MtCIR1 |
| Epistasis and transactivator assays | Genetic interactions between lncRNA and protein partners | Fungal lncRNA-transactivator studies |
| Hormone/ligand treatment | Signal-dependent lncRNA repression | Vitamin D and OIP5-AS1 axis in Th17 cells |
RNA-seq and lncRNA expression profiling
RNA-seq is the primary method to quantify lncRNA abundance after perturbation of candidate repressors. In osteoclastogenesis, lncRNA expression profiles revealed negative regulation of lncRNA-NOMMUT037835.2 during differentiation. In triple-negative breast cancer, RNA-seq-based profiling has been used to map miRNA and lncRNA networks. Combining total RNA-seq with ribo-depletion improves detection of low-abundance lncRNAs.
Chromatin immunoprecipitation and epigenetic assays
ChIP-seq and related assays identify where repressive complexes bind lncRNA loci. The MTA1-HDAC1/2 complex is recruited by HOXA-AS2 to cccDNA minichromosomes, and ChIP-based methods can resolve this binding. Histone acetylation and methylation status at lncRNA promoters can be measured to confirm repressive chromatin changes.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes whose loss increases lncRNA transcription, directly mapping negative regulators. Such screens are particularly useful in cancer models where lncRNA networks are dysregulated. Coupling screens with lncRNA reporter cassettes enables quantitative readouts of GO:0140744 activity.
Non-mammalian and stress models
Plant and fungal systems provide complementary genetic models. In Medicago truncatula, MtCIR1 negatively regulates seed germination under salt stress in association with alternative splicing, and splicing-sensitive assays can be applied. In fungi, lncRNA action on a transactivator can be dissected with genetic epistasis and reporter assays.
How CRISPR Can Be Used to Study GO:0140744 negative regulation of lncRNA transcription
Knockout
CRISPR knockout of candidate repressors such as HDAC1, HDAC2 or MTA1 can test whether they are required for negative regulation of lncRNA transcription. Loss of the MTA1-HDAC1/2 complex would be predicted to increase target lncRNA transcription, and this can be measured by RNA-seq. Knockout of lncRNA loci themselves, such as HOXA-AS2 or OIP5-AS1, can reveal downstream effects on target genes.
Point Mutation
Point-mutation knock-in of catalytic residues in deacetylases or interaction surfaces in MTA1 can separate enzymatic activity from scaffolding function. Such models are valuable for testing whether deacetylation per se is required for lncRNA repression. Point mutations in transcription factor binding sites within lncRNA promoters can also define the cis-elements that mediate repression.
Knock-in
Tagged knock-in of repressive complex subunits, for example HDAC1-FLAG or MTA1-HA, enables ChIP-seq and proteomics to identify the genomic sites and protein partners involved in lncRNA repression. Knock-in of reporter cassettes at lncRNA loci allows real-time monitoring of transcriptional repression in live cells.
Overexpression
Doxycycline-inducible overexpression of lncRNAs such as HOXA-AS2 or OIP5-AS1 can test whether increased lncRNA dosage is sufficient to repress target transcription. Overexpression of candidate repressors can also be used to confirm gain-of-repression phenotypes in cancer and immune cell models.
How EDITGENE Supports negative regulation of lncRNA transcription Research
Researchers studying negative regulation of lncRNA transcription-related genes often need to determine whether a candidate gene is causally involved in repressing a specific lncRNA locus, and whether that repression depends on enzymatic activity, protein-protein interactions or cis-regulatory elements. EDITGENE provides the full pipeline of CRISPR cell models and screening services required to answer these questions rigorously.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of lncRNA transcription research.
Frequently Asked Questions About negative regulation of lncRNA transcription
What is GO:0140744 negative regulation of lncRNA transcription?
GO:0140744 is a Gene Ontology biological process defined as any process that decreases the frequency, rate or extent of the synthesis of a lncRNA.
What genes are involved in negative regulation of lncRNA transcription?
Genes and proteins implicated include MTA1, HDAC1, HDAC2, HOXA-AS2, SOX9, OIP5-AS1, MIR26A5P, IL6 and NOMMUT037835.2, among others.
How is lncRNA transcription repressed?
Repression often involves recruitment of deacetylase complexes such as MTA1-HDAC1/2 to target loci, chromatin modification, and inhibition of RNA polymerase II elongation.
Which diseases are linked to negative regulation of lncRNA transcription?
Links have been reported to triple-negative breast cancer, HBV infection, ulcerative colitis, osteoclast-driven bone disease and plant salt stress responses.
What methods are used to study negative regulation of lncRNA transcription?
Common methods include RNA-seq, ChIP-seq, histone modification assays, CRISPR knockout screening, reporter assays and hormone treatment experiments.
Can CRISPR knockout be used to study lncRNA repression?
Yes, CRISPR knockout of candidate repressors or lncRNA loci is widely used to test causality in negative regulation of lncRNA transcription.
What is the role of HDAC1 and HDAC2 in lncRNA repression?
HDAC1 and HDAC2 are histone deacetylases that, as part of the MTA1-HDAC1/2 complex, remove acetyl marks and repress transcription at target loci.
How does vitamin D affect lncRNA repression?
Vitamin D reduces Th17 differentiation in ulcerative colitis by targeting the lncRNA OIP5-AS1/miR-26a-5p/IL-6 axis, showing hormonal control of lncRNA networks.
Is negative regulation of lncRNA transcription conserved in plants?
Yes, in Medicago truncatula the lncRNA MtCIR1 negatively regulates seed germination under salt stress in association with alternative splicing.
How can I model negative regulation of lncRNA transcription with CRISPR?
EDITGENE offers knockout, point-mutation, knock-in, tagged knock-in, overexpression and CRISPR library screening services tailored to lncRNA repression studies.
Conclusion
GO:0140744 negative regulation of lncRNA transcription defines the processes that reduce lncRNA synthesis and is emerging as a central control layer in cancer, viral infection, inflammation and bone biology. Mechanistic studies have identified deacetylase complexes, hormone-responsive networks and lncRNA-directed effectors as key players. Combining CRISPR knockout, point-mutation, knock-in and overexpression models with RNA-seq, ChIP-seq and library screening provides a rigorous path to causal understanding. EDITGENE supports these efforts with end-to-end cell model generation and bioinformatics services.
References
- 1. Chang Y et al.. 2020. LncRNA expression profiles and the negative regulation of lncRNA-NOMMUT037835.2 in osteoclastogenesis.. Bone 130:115072 PMID: 31593824
- 2. Tian R et al.. 2026. Negative regulation of seed germination in Medicago truncatula by the lncRNA MtCIR1 under salt stress is associated with alternative splicing.. Plant Sci 372:113391 PMID: 42633861
- 3. Xu J et al.. 2020. Roles of miRNA and lncRNA in triple-negative breast cancer.. J Zhejiang Univ Sci B 21(9):673-689 PMID: 32893525
- 4. Qin Y et al.. 2024. HOXA-AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1-HDAC1/2 Deacetylase Complex to cccDNA Minichromosome.. Adv Sci (Weinh) 11(24):e2306810 PMID: 38647380
- 5. Tariq A et al.. 2020. LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells.. RNA 26(2):175-185 PMID: 31690584
- 6. Till P et al.. 2020. Regulation of gene expression by the action of a fungal lncRNA on a transactivator.. RNA Biol 17(1):47-61 PMID: 31517564
- 7. Vishnubalaji R et al.. 2021. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.. Sci Rep 11(1):15410 PMID: 34326372
- 8. Zhu C et al.. 2022. Vitamin D Reduces the Helper T Cells 17 (Th17) Differentiation in Patients with Ulcerative Colitis by Targeting Long Non-coding RNA (lncRNA) OIP5-AS1/miR-26a-5p/IL-6 Axis.. Iran J Immunol 19(2):150-160 PMID: 35767888
